COMMON STOCK PURCHASE WARRANT To purchase shares of common stock, $0.0001 par value, of Rock Creek Pharmaceuticals, Inc.Rock Creek Pharmaceuticals, Inc. • May 12th, 2015 • Medicinal chemicals & botanical products
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Feehan Partners, L.P. (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after May 8, 2019 (the “Initial Exercise Date”) and on or prior to the close of business on May 8, 2022 (the “Termination Date”) but not thereafter (the “Exercise Period”), to subscribe for and purchase from Rock Creek Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to 69,831 shares (the “Warrant Shares”) of common stock, par value $0.0001 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $3.00, subject to adjustment hereunder. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein. The term “Holder” shall refer to the Holder identified abo
SECURITIES PURCHASE AGREEMENT Between ROCK CREEK PHARMACEUTICALS, INC., as Issuer, And FEEHAN PARTNERS, LP, as Investor.Securities Purchase Agreement • May 12th, 2015 • Rock Creek Pharmaceuticals, Inc. • Medicinal chemicals & botanical products • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is entered into and effective as of May 8, 2015, between Rock Creek Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Feehan Partners, LP (“Investor”).
